Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-632-7 | CAS number: 108-95-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Neurotoxicity
Administrative data
- Endpoint:
- neurotoxicity: sub-chronic oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The Pesticide Assessment Guidelines, Subdivision F, Series 82-7 (PB91-154617) were followed; this guideline is comparable with OECD Guideline 424. Minor restriction: no ophthalmological examination.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Pesticide Assessment Guidelines, Subdivision F, Series 82-7 (PB91-15461J7); comparable to OECD Guideline 424
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Phenol
- EC Number:
- 203-632-7
- EC Name:
- Phenol
- Cas Number:
- 108-95-2
- Molecular formula:
- C6H6O
- IUPAC Name:
- phenol
- Details on test material:
- - Physical state: white cristalline powder
- Analytical purity: 100% (determined by GC/TCD area%)
- Impurities (identity and concentrations): impurities >0.1% were not detected; water content 0.02%
- Purity test date: 1997-01-17
- Lot/batch No.: 112796/102596
- Stability under test conditions: stability and homogeneity of drinking water solutions were analysed; acceptance criteria (± 10% of target concentration) fullfilled (dose formulations prepared for administration to the animals during weeks 1, 7 and 13)
- Storage condition of test material: glass container (nitrogen blanket) at RT in the dark
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Crl:CD®(SD)BR
- Source: Charles River Canada Inc., St. Constant, Quebec
- Age at study initiation: appr. 7 weeks
- Weight at study initiation: 210 to 292 g (males) or 155 to 199 g (fema!es)
- Fasting period before study: no
- Housing: individually
- Diet (ad libitum except during behavioral evaluations): certified diet, analysed for contaminations
- Water (ad libitum except during behavioral evaluations): Municipal tap water which had been further treated by reverse osmosis and ultraviolet sterilization
- Acclimation period: 2 we
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 30-70
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: drinking water
- Vehicle:
- water
- Details on exposure:
- Randomization approximately one week before treatment initiation (all animals weighed and 15 males and 15 females assigned to each of 4 groups using a computer-based selection procedure). Five rats/sex/group for the following phases of the study: perfusion after 13 weeks of treatment, perfusion at the end of the recovery period of 4 weeks, and necropsy at the end of the recovery period of 4 weeks.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Stability and homogeneity of drinking water solutions were analysed; acceptance criteria (± 10% of target concentration) fullfilled (dose formulations prepared for administration to the animals during weeks 1, 7 and 13).
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- daily ad libitum
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 200, 1000, 5000 ppm
Basis:
nominal in water
- Remarks:
- Doses / Concentrations:
18, 83, 308 mg/kg bw/day for males
Basis:
actual ingested
mean values
- Remarks:
- Doses / Concentrations:
25, 107, 360 mg/kg bw/day for females
Basis:
actual ingested
mean values
- No. of animals per sex per dose:
- 15
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- Post exposure observation period in the recovery group: 4 weeks
Examinations
- Observations and clinical examinations performed and frequency:
- Rats examined twice daily; a complete detailed examination was performed weekly.
Body weight: weighed weekly including days of behavioral testing as well as prior to terminal sacrifice.
Food consumption: Individual food consumption measured weekly including one week prior to treatment start.
Water consumption: Individual water consumption measured daily including the week prior to treatment start.
Body temperature measured once prior to initiation and at treatment week 4, 8, 13, and week 4 of recovery period - Specific biochemical examinations:
- no data
- Neurobehavioural examinations performed and frequency:
- Functional Observational Battery (FOB)
All animals tested prior to the initiation and once during the 4th, 8th and 13th weeks of treatment. In addition, recovery phase animals (1O/sex/group) were tested during the 4th week of the recovery period.
Qualitative
Observations in home cage: body position, tremors, twitches, convulsions, bizarre/stereotypic behavior
Removal from home cage: ease of removal, vocalization, observations in arena, rearing, ataxie, hypotonic and impaired gait, overall gait incapacity, bizarre/stereotypic behavior, palpebra1 closure, tremors, twitches, convulsions, piloerection, respiratory rate/pattern, locomotor activity level, arousal, grooming, defecation, urination, olfactory response
Handling observations: lacrimation, pupil size, salivation, urinary staining, diarrhea, body tone, extensor thrust, corneal reflex, pinna reflex, toe and tail pinch, visual placing,
On Surface: auricular startle, air righting reflex, positional passivity.
Quantitative: hindlimb and forelimb grip testing, hindlimb splay, motor activity (sessions of 1-hour duration and activity counts recorded). - Sacrifice and (histo)pathology:
- After 13 weeks of treatment, 5 rats/sex/dose were deeply anesthetized and perfused with lactated Ringer's solution followed by 3% glutaraldehyde & 3% paraformaldehyde in 0.1 M cacodylate buffer (pH 7.3 to 7.5). Same procedures were performed on 5 rats/sex/group euthanized after a 4-week recovery period.
Tissues from the high dose and control animals were processed for neuropathological evaluation. The nervous system tissues of animals in all groups were grossly examined at the time of sampling and any pathology observed was recorded.
Tissues for paraffin embedding and light microscopy:
Brain (6 levels) - forebrain (through the septum), center of the cerebrum (through the hypothalamus), midbrain, cerebellum and pons, midcerebellum and medulla oblongata, and medulla oblongata. Spinal cord - cervical and lumbar (cross-section). Brain weight (excluding olfactory bulbs), length and maximum coronal width were recorded prior to trimming.
Tissues for Epoxy Embedding:
Sciatic nerve (mid-thigh region) (cross-section)
Sciatic nerve (at sciatic notch) (longitudinal and cross-sections)
Sural nerve (at knee) (cross-section)
Tibial nerve (at knee) (longitudinal and cross-sections)
Gasserian ganglion - left (cross-section)
Lumbar dorsal root ganglion (L4) (cross-section)
Lumbar dorsal root (L4) (cross-section)
Lumbar ventral root (L4) (longitudinal and cross-sections)
Cervical dorsal root ganglion (C5) (cross-section)
Cervical dorsal root (C5) (cross-section)
Cervical ventral root (C5) (cross-section)
Grossly abnormal central or peripheral nervous system tissues.
All other animals: necropsy performed, tissue preserved in 10% formalin - Other examinations:
- no
- Positive control:
- no
- Statistics:
- Group variances Bartlett's test; when the differences between group variances were not significant (P>0.001), a one-way analysis of variance (ANOVA) was performed. If significant differences (P<0.05) were indicated by the ANOVA, Dunnett's test was used to compare the control and treated groups. When the differences between group variances were significant (P<0.001) by Bartlett's test, the Kruskal-Wallis test was then performed. Where significant differences (P<0.05) between the groups were indicated by the Kruskal-Wallis test, the values for the control and treated groups were compared using Dunn's test (or WilcoxonIMann Whitney "U" test).
Qualitative FOB data analyzed by Fisher's exact probability test.
Level of significance declared at 0.05.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Mortality:
- mortality observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- effects observed, treatment-related
- Ophthalmological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Behaviour (functional findings):
- no effects observed
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- no effects observed
- Details on results:
- Mortality and clinical signs
5000 ppm: One female was euthanized on day 14 due to poor condition (dehydratation, hunched posture/prominent backbone/thin/weak appearance, uncoordinated movements, tremors, reduced activity, pallor, partly closed eyes, reduced body temperature). One male and 1 female showed dedydration, hunched posture/prominent backbone/thin appearance, reduced activity, decreased feces and fur staining. Nine females and seven males showed a dehydrated appearance commencing as early as the end of week 1; one male and six females showed a prominent backbone/thin appearance.
1000 ppm: two males and two females showed a dehydrated appearance commencing as early as the end of week 1.
200 ppm: no treatment related effects.
Body weight
200 & 1000 ppm: no significant effects
5000: mean body weights in males and females significantly reduced during treatment period but rats showed marked gains in body weight during the recovery period (in males no significant difference compared with control).
Food consumption
No significant differences in mean food consumption were noted between the control and 200 or 1000 ppm groups during the treatment period.
5000 ppm: significant decrease in males and females during exposure period and significant increase in males during recovery period.
Water Consumption
5000 ppm: mean daily water consumption significantly (P1000 ppm: On occasion, significant reductions in mean daily water intake in males and females; at other times, the water intake of the 1000 ppm rats was generally lower than control values.
200 ppm: no significant differences detected.
Body temperature
A significant decrease in body temperature was noted for males in the 1000 and 5000 ppm groups at the week 13. However, as these values fell within the historical control range (37.1 to 38.4°C) together with the absence of FOB findings, this was considered not to be of toxicological significance.
Functional Observational Battery (FOB) and Motor Activity
No behavioral changes were observed for animals treated with phenol.
Exception: At the week 4 a significant (P< 0.01) reduction in total counts in motor activity was observed for 5000 ppm females. Correlation of the total counts of individual animals with dehydration shows that while the control group had an average increase of > than 20% at week 4 compared to the prestudy evaluation, females in the 5000 ppm group with dehydration had an average decrease of 17%; however, females without dehydration had an average increase of 2% over prestudy values suggesting that the decrease in motor activity was secondary to markedly lower (40-50% of control) water intake.
Other changes at 1000 and 5000 ppm were also considered not to be of neurotoxicological significance.
Brain weight
No effects on organ weight detected in brains of perfused animals.
Gross pathological evaluation
There were no necropsy findings considered treatment-related
Neuropathology
There were no gross or histopathological findings following treatment and no gross pathological findings following recovery in nervous tissue for males or females that were considered treatment related.
Effect levels
open allclose all
- Dose descriptor:
- NOEL
- Effect level:
- 200 ppm
- Sex:
- male/female
- Basis for effect level:
- other: effects secondary to reduced water intake; dose corresponding to 18 mg/kg bw/day in males and 25 mg/kg bw/day in females
- Remarks on result:
- other:
- Dose descriptor:
- NOAEL
- Effect level:
- 5 000 ppm
- Sex:
- male/female
- Basis for effect level:
- other: neurotoxicity; corresponding to 360 mg/kg bw/day for females and 308 mg/kg bw/day for males
- Remarks on result:
- other:
Applicant's summary and conclusion
- Conclusions:
- In male and female rats the NOAEL for neurotoxic effects was 5000 ppm in a 13 week drinking water study. The NOEL concerning overall effects was 200 ppm.
- Executive summary:
The Pesticide Assessment Guidelines, Subdivision F, Series 82 -7 (PB91 -154617) were followed; this guideline is comparable with OECD Guideline 424. Minor restriction: no ophthalmological examination.
In a drinking water study 15 rats per dose per sex were exposed to 0, 200, 1000, or 5000 ppm for 13 weeks. Five rats/sex/group were used for the following phases of the study: perfusion after 13 weeks of treatment, perfusion at the end of the recovery period of 4 weeks, and necropsy at the end of the recovery period of 4 weeks.
At a concentration of 5000 ppm lower body weight, reduced food and water consumption and abnormal clinical signs including dehydrated appearance was reported; one female was sacrificed due to poor condition. At 1000 ppm, decreased water intake and on occasion dehydrated appearance were seen. Marked improvements were noted following recovery. No effects were noted for any parameters at 200 ppm. Neurobehavioral evaluations (functional observation battery) did not reveal any findings of neurotoxicological significance at any concentration following treatment or recovery. Observations of altered motor activity (females only) were noted, however, these findings were considered to be secondary to the reduction in water and/or food intake. No gross or histopathological lesions in nervous tissue attributed to treatment with phenol were detected. Based on these findings, a NOAEL for neurotoxicity under the conditions of this study was 5000 ppm (308 and 360 mg/kg bw/day for males and females, respectively). The overall study NOEL under the conditions of this study was 200 ppm (18 and 25 mg/kg bw/day for males and females, respectively).
Conclusion: In male and female rats the NOAEL for neurotoxic effects was 5000 ppm in a 13 week drinking water study. The NOEL concerning overall effects was 200 ppm.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.